By Drug Target Review2025-07-01T14:41:16
AI is changing how clinical trials are run - quietly but significantly. Find out how digital twins are helping sponsors reduce control arms and accelerate development without changing trial endpoints.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-05-31T15:16:10
Sponsored by Bio-Techne
2023-03-03T14:06:14
Sponsored by Bio-Techne
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2023-03-08T16:29:20
Sponsored by Bio-Techne
2024-01-19T07:40:55
Sponsored by Euretos
Site powered by Webvision Cloud